News
All NewsBlogs
Media
All VideosCase-Based Roundtable SeriesEichenbaum AcornsExpert InterviewsEyeviewsInsightsMedical World NewsPodcastsRapid ReadoutsThe Retina TL;DRViewpoints
Conference
Conference CoverageConference Listing
Publications
Modern Retina Digital EditionSupplements And Featured Publications
More
Resources
Between the LinesCME/CEEYLEA 8mg for nAMD and DME TreatmentSponsored Resources
Partners

Subscribe

  • News
  • Media
  • Conference
  • Publications
  • Resources
  • Partners
  • Subscribe
  • AMD
    • Wet AMD
  • Biosimilar
  • Diabetic Macular Edema
    • Diabetic Eye Awareness
  • Diabetic Retinopathy
  • Geographic Atrophy
  • Imaging
  • Inherited Retinal Diseases
  • Ophthalmology
    • Europe
  • RVO
  • Retina Technology
  • Retinal Surgery
  • Uveitis
Spotlight -
Geographic Atrophy
Advertisement
Opinion|Videos|July 19, 2024

Complement-based Therapies for Geographic Atrophy (GA)

Author(s)Murtaza Adam, MD

Murtaza Adam, MD, opens a discussion surrounding complement therapies for patients diagnosed with geographic atrophy.

Advertisement

Episodes in this series

EP. 1 Complement-based Therapies for Geographic Atrophy (GA)
Now Playing
EP. 1 Complement-based Therapies for Geographic Atrophy (GA)
EP. 2 A case of a 70-year-old female with fovea-threatening GA
EP. 2 A case of a 70-year-old female with fovea-threatening GA
EP. 3 A case of a 79-year-old female with cataracts and GA
EP. 3 A case of a 79-year-old female with cataracts and GA
EP. 4 A case of a 79-year-old pseudophakic patient with AMD and rapidly progressing GA
EP. 4 A case of a 79-year-old pseudophakic patient with AMD and rapidly progressing GA

Newsletter

Keep your retina practice on the forefront—subscribe for expert analysis and emerging trends in retinal disease management.

Subscribe Now!
Advertisement

Related Content

Advertisement

FLORetina 2025: Antithrombotic use examined in wet AMD submacular hemorrhage

BySharon Fekrat, MD, FASRS,Sheryl Stevenson,Kassi Filkins
December 6th 2025
(Image credit: Modern Retina) The Retina TL;DR: Redefining office-based surgery for retina care with Jonathan Feistmann, MD

The Retina TL;DR: Redefining office-based surgery for retina care with Jonathan Feistmann, MD

ByChristina Y. Weng, MD, MBA, FASRS,Jonathan Feistmann, MD
November 1st 2025
Ashkan Abbey, MD, FASRS, FAAO, speaks about the outcomes of EYP-1901 for AMD and DME ahead of the 2025 American Academy of Ophthalmology meeting. Concept image for AAO, reducing the number of injections and treatment burden for patients in retinal disease.

AAO 2025: Ashkan Abbey on the outcomes of EYP-1901 for AMD and DME

ByAshkan Abbey, MD,Sydney M Crago
October 17th 2025

Part 6: KOL reflections on what they would say to retina fellows

ByKassi Filkins
October 10th 2025
Jay Chhablani, MD, shares late-breaking data from the ARMADA trial, investigating gene therapy for Geographic Atrophy and dry age-related macular degeneration, at EURETINA

Jay Chhablani, MD, reviews late-breaking findings from the ArMaDa trial

ByJay Chhablani, MD,Hattie Hayes
October 9th 2025
Advertisement
Advertisement

Trending on Modern Retina

1

A medical fellow finds some magic at the AAO Annual Meeting

  • About
  • Advertise
  • Editorial
  • Contact Us
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us